288 related articles for article (PubMed ID: 15469075)
21. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
[TBL] [Abstract][Full Text] [Related]
22. Esthesioneuroblastoma: is there a need for elective neck treatment?
Demiroz C; Gutfeld O; Aboziada M; Brown D; Marentette LJ; Eisbruch A
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e255-61. PubMed ID: 21676553
[TBL] [Abstract][Full Text] [Related]
23. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
24. Treatment modalities and outcomes of olfactory neuroblastoma.
Song CM; Won TB; Lee CH; Kim DY; Rhee CS
Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
[TBL] [Abstract][Full Text] [Related]
25. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analysis of 53 cases of esthesioneuroblastoma].
Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ
Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448
[TBL] [Abstract][Full Text] [Related]
27. Patterns of failure and outcome in esthesioneuroblastoma.
Dias FL; Sa GM; Lima RA; Kligerman J; Leoncio MP; Freitas EQ; Soares JR; Arcuri RA
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1186-92. PubMed ID: 14623748
[TBL] [Abstract][Full Text] [Related]
28. Esthesioneuroblastoma: 25-year experience at a single institution.
Zafereo ME; Fakhri S; Prayson R; Batra PS; Lee J; Lanza DC; Citardi MJ
Otolaryngol Head Neck Surg; 2008 Apr; 138(4):452-8. PubMed ID: 18359353
[TBL] [Abstract][Full Text] [Related]
29. Olfactory neuroblastoma: 15 years of experience.
Kondo N; Takahashi H; Nii Y; Nagao J
Anticancer Res; 2012 May; 32(5):1697-703. PubMed ID: 22593448
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
[TBL] [Abstract][Full Text] [Related]
31. [Cancer of the nasal cavity].
Hu WH; Xie FY; Fang SH; Jiao JJ; Yan C; Peng WJ; Fu XY; Zhang F
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):117-21. PubMed ID: 15946555
[TBL] [Abstract][Full Text] [Related]
32. [Classification and prognosis of esthesioneuroblastoma based on 7 treated cases].
Zumegen C; Michel O
Laryngorhinootologie; 2000 Dec; 79(12):736-42. PubMed ID: 11199456
[TBL] [Abstract][Full Text] [Related]
33. [Cystic adenoid carcinomas (cylindromas) and olfactory esthesio-neuromas of the nasal cavities and paranasal sinuses. Experience of the ORL Group of the National Federation of Cancer Centers].
Schwaab G; Lefebvre JL; Julieron M
Neurochirurgie; 1997; 43(2):118-20. PubMed ID: 9296055
[TBL] [Abstract][Full Text] [Related]
34. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients.
Xiong L; Zeng XL; Guo CK; Liu AW; Huang L
BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835
[TBL] [Abstract][Full Text] [Related]
35. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
Yao B; Li YX; Fang H; Yu ZH; Jin J; Liu XF
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
[TBL] [Abstract][Full Text] [Related]
37. [Radiotherapy of esthesioneuroblastoma].
Strnad V; Grabenbauer GG; Dunst J; Sauer R
Strahlenther Onkol; 1994 Feb; 170(2):79-84. PubMed ID: 8108785
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
39. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
40. [Prognosis and treatment for 98 patients with carcinoma of nasal cavity].
Hu WH; Xie FY; Chen DZ; Wu Y; Jiao JJ; Peng WJ; Yan C; Fang SH
Ai Zheng; 2004 Nov; 23(11 Suppl):1542-5. PubMed ID: 15566676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]